Pharmaceutical & Biopharmaceutical Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 By Sector (Pharmaceutical, Biopharmaceutical), By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage Formulation (Tablet, Capsule, Oral Liquids, Parenteral/Injectables, Others), Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Others), By Service (Pharmaceutical Manufacturing Services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services), Biologics Manufacturing Services (Biologics FDF Manufacturing Services, Biologics API Manufacturing Services), Drug Development Services), By Drug Type (Originator / Patented, Generics, Biosimilar), By Region, Forecast & Opportunities, 2028

December 2022 | 112 pages | ID: P651C6D7909FEN
TechSci Research

Abstracts

Global pharmaceutical & biopharmaceutical contract manufacturing market is expected to register significant growth during the forecast period, 2024-2028. The increasing focus on contract manufacturing companies in expanding their capabilities to manufacture biological drugs, along with establishing new services to meet the growing demand of biopharmaceutical companies, which is expected to bolster the growth of the market. Further, the increasing investment in advanced manufacturing technologies by Contract Development & Manufacturing Organizations (CDMOs) is a major factor, which is anticipated to drive the market growth in coming years. Also, increasing drug development and manufacturing activities by pharmaceutical companies is propelling the growth of global pharmaceutical & biopharmaceutical contract manufacturing market. For instance, in 2022, INCOG BioPharma Services, the Indiana-based contract development and manufacturing organization (CDMO) which specialize in sterile injectables, unveiled that the construction of its manufacturing facility and global headquarters in Fishers, is almost completed.

Contract manufacturing is a form of outsourcing where a manufacturing company enters into an agreement with another manufacturing firm to develop innovative products and services.

Global pharmaceutical & biopharmaceutical contract manufacturing market is segmented into sector, product type, service, drug type, company, and region. Based on service type, the market is segmented into pharmaceutical manufacturing services, biologics manufacturing services and drug development services. The pharmaceutical manufacturing services is further segmented into pharmaceutical API manufacturing services and pharmaceutical FDF manufacturing services. Similarly, the biologics manufacturing services is segmented into biologic FDF manufacturing services and biologics API manufacturing services. Among these, the pharmaceutical manufacturing services holds largest market share and is expected to witness fastest growth during the forecast period. This is attributed to the increasing number of sterile formulations and intensive drug development activities.

Based on region, Asia Pacific is expected to register fastest growth during the forecast period owing to improving healthcare infrastructure and availability of highly skilled workforce. Many pharmaceutical companies are setting up their manufacturing units in countries such as China and India, due to low manufacturing and operational costs. Therefore, making Asian countries hub for outsourcing.

Major companies operating in global pharmaceutical & biopharmaceutical contract manufacturing market include Jubilant Pharmova Limited, JRS PHARMA GmbH & Co, Boehringer Ingelheim GmbH, Lonza Group, Rentschler Biotechnologie GmbH, Inno Biologics Sdn Bhd, INCOG BioPharma Services, Baxter Biopharma Solutions, Catalent Pharma Solutions, and Kemwell Biopharma Private Limited. Leading companies are continuously carrying out research and development activities to bring new medicines. Also, favourable regulations by government in regions such as Asia Pacific is enabling manufacturers to expand their businesses efficiently.

Objective of the Study:

• To analyze and forecast the market size of global pharmaceutical & biopharmaceutical contract manufacturing market.
• To forecast global pharmaceutical & biopharmaceutical contract manufacturing market based on sector, product type, service, drug type and regional distribution.
• To identify drivers and challenges for global pharmaceutical & biopharmaceutical contract manufacturing market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global pharmaceutical & biopharmaceutical contract manufacturing market.
• To identify and analyze the profile of leading players operating in the global pharmaceutical & biopharmaceutical contract manufacturing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of pharmaceutical & biopharmaceutical manufacturing companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global pharmaceutical & biopharmaceutical contract manufacturing market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

• Pharmaceutical & biopharmaceutical manufacturers/companies and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, industry associations, forums and alliances related to pharmaceutical & biopharmaceutical contract manufacturing
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as pharmaceutical & biopharmaceutical contract manufacturing companies, partners, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global pharmaceutical & biopharmaceutical contract manufacturing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Sector:
• Pharmaceutical
• Biopharmaceutical
• Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Product Type:
• Active Pharmaceutical Ingredients (API)
• Finished Dosage Formulation
• Tablet
• Capsule
• Oral Liquids
• Parenteral/Injectables
• Others
• Advanced Drug Delivery Products
• Over the Counter (OTC) Medicines
• Nutritional Products
• Others
• Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Service:
• Pharmaceutical Manufacturing Services
• Pharmaceutical API Manufacturing Services
• Pharmaceutical FDF Manufacturing Services
• Biologics Manufacturing Services
• Biologics FDF Manufacturing Services
• Biologics API Manufacturing Services
• Drug Development Services
• Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Drug Type:
• Originator / Patented
• Generics
• Biosimilar
• Global Pharmaceutical & Biopharmaceutical Contract Manufacturing Market, By Region:
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• North America
• United States
• Mexico
• Canada
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• UAE
• South Africa
• Saudi Arabia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global pharmaceutical & biopharmaceutical contract manufacturing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

• Profit margin analysis in case of direct and indirect sales channel.

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. GLOBAL PHARMACEUTICAL & BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

5.1. Market Size & Forecast
  5.1.1. By Value
5.2. Market Share & Forecast
  5.2.1. By Sector (Pharmaceutical, Biopharmaceutical)
  5.2.2. By Product Type (Active Pharmaceutical Ingredients (API), Finished Dosage, Formulation Advanced Drug Delivery Products, Over the Counter (OTC) Medicines, Nutritional Products, Others)
    5.2.2.1. By Finished Dosage (Tablet, Capsule, Oral Liquids, Parenteral/Injectables, Others)
  5.2.3. By Service (Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services)
    5.2.3.1. By Pharmaceutical Manufacturing services (Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services)
    5.2.3.2. By Biologics Manufacturing Services (Biologics FDF Manufacturing Services, Biologics API Manufacturing Services)
  5.2.4. By Drug Type (Originator / Patented, Generics, Biosimilar)
  5.2.5. By Company (2022)
  5.2.6. By Region
5.3. Market Attractiveness Index

6. ASIA-PACIFIC PHARMACEUTICAL & BIOPHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Sector
  6.2.2. By Product Type
  6.2.3. By Service
  6.2.4. By Drug Type
  6.2.5. By Country
6.3. Competition Outlook
6.4. Asia-Pacific: Country Analysis
  6.4.1. China Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook
    6.4.1.1. Market Size & Forecast
      6.4.1.1.1. By Value
    6.4.1.2. Market Share & Forecast
      6.4.1.2.1. By Sector
      6.4.1.2.2. By Product Type
      6.4.1.2.3. By Service
      6.4.1.2.4. By Drug Type
  6.4.2. India Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook
    6.4.2.1. Market Size & Forecast
      6.4.2.1.1. By Value
    6.4.2.2. Market Share & Forecast
      6.4.2.2.1. By Sector
      6.4.2.2.2. By Product Type
      6.4.2.2.3. By Service
      6.4.2.2.4. By Drug Type
  6.4.3. Japan Pharmaceutical & Biopharmaceutical Contract Manufacturing Market Outlook
    6.4.3.1. Market Size & Forecast
      6.4.3.1.1. By Value
    6.4.3.2. Market Share & Forecast
      6.4.3.2.1. By Sector
      6.4.3.2.2. By Product Type
      6.4.3.2.3. By Service
      6.4.3.2.4. By Drug Type
  6.4.4. South Korea Pharmaceutical Contract Manufacturing Market Outlook
    6.4.4.1. Market Size & Forecast
      6.4.4.1.1. By Value
    6.4.4.2. Market Share & Forecast
      6.4.4.2.1. By Sector
      6.4.4.2.2. By Product Type
      6.4.4.2.3. By Service
      6.4.4.2.4. By Drug Type
  6.4.5. Australia Pharmaceutical Contract Manufacturing Market Outlook
    6.4.5.1. Market Size & Forecast
      6.4.5.1.1. By Value
    6.4.5.2. Market Share & Forecast
      6.4.5.2.1. By Sector
      6.4.5.2.2. By Product Type
      6.4.5.2.3. By Service
      6.4.5.2.4. By Drug Type
  6.4.6. Singapore Pharmaceutical Contract Manufacturing Market Outlook
    6.4.6.1. Market Size & Forecast
      6.4.6.1.1. By Value
    6.4.6.2. Market Share & Forecast
      6.4.6.2.1. By Sector
      6.4.6.2.2. By Product Type
      6.4.6.2.3. By Service
      6.4.6.2.4. By Drug Type

7. EUROPE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Sector
  7.2.2. By Product Type
  7.2.3. By Service
  7.2.4. By Drug Type
  7.2.5. By Country
7.3. Competition Outlook
7.4. Europe: Country Analysis
  7.4.1. France Pharmaceutical Contract Manufacturing Market Outlook
    7.4.1.1. Market Size & Forecast
      7.4.1.1.1. By Value
    7.4.1.2. Market Share & Forecast
      7.4.1.2.1. By Sector
      7.4.1.2.2. By Product Type
      7.4.1.2.3. By Service
      7.4.1.2.4. By Drug Type
  7.4.2. Germany Pharmaceutical Contract Manufacturing Market Outlook
    7.4.2.1. Market Size & Forecast
      7.4.2.1.1. By Value
    7.4.2.2. Market Share & Forecast
      7.4.2.2.1. By Sector
      7.4.2.2.2. By Product Type
      7.4.2.2.3. By Service
      7.4.2.2.4. By Drug Type
  7.4.3. United Kingdom Pharmaceutical Contract Manufacturing Market Outlook
    7.4.3.1. Market Size & Forecast
      7.4.3.1.1. By Value
    7.4.3.2. Market Share & Forecast
      7.4.3.2.1. By Sector
      7.4.3.2.2. By Product Type
      7.4.3.2.3. By Service
      7.4.3.2.4. By Drug Type
  7.4.4. Italy Pharmaceutical Contract Manufacturing Market Outlook
    7.4.4.1. Market Size & Forecast
      7.4.4.1.1. By Value
    7.4.4.2. Market Share & Forecast
      7.4.4.2.1. By Sector
      7.4.4.2.2. By Product Type
      7.4.4.2.3. By Service
      7.4.4.2.4. By Drug Type
  7.4.5. Spain Pharmaceutical Contract Manufacturing Market Outlook
    7.4.5.1. Market Size & Forecast
      7.4.5.1.1. By Value
    7.4.5.2. Market Share & Forecast
      7.4.5.2.1. By Sector
      7.4.5.2.2. By Product Type
      7.4.5.2.3. By Service
      7.4.5.2.4. By Drug Type

8. NORTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Sector
  8.2.2. By Product Type
  8.2.3. By Service
  8.2.4. By Drug Type
  8.2.5. By Country
8.3. Competition Outlook
8.4. North America: Country Analysis
  8.4.1. United States Pharmaceutical Contract Manufacturing Market Outlook
    8.4.1.1. Market Size & Forecast
      8.4.1.1.1. By Value
    8.4.1.2. Market Share & Forecast
      8.4.1.2.1. By Product Type
      8.4.1.2.2. By Service
      8.4.1.2.3. By Application
      8.4.1.2.4. By End User
  8.4.2. Mexico Pharmaceutical Contract Manufacturing Market Outlook
    8.4.2.1. Market Size & Forecast
      8.4.2.1.1. By Value
    8.4.2.2. Market Share & Forecast
      8.4.2.2.1. By Sector
      8.4.2.2.2. By Product Type
      8.4.2.2.3. By Service
      8.4.2.2.4. By Drug Type
  8.4.3. Canada Pharmaceutical Contract Manufacturing Market Outlook
    8.4.3.1. Market Size & Forecast
      8.4.3.1.1. By Value
    8.4.3.2. Market Share & Forecast
      8.4.3.2.1. By Sector
      8.4.3.2.2. By Product Type
      8.4.3.2.3. By Service
      8.4.3.2.4. By Drug Type

9. SOUTH AMERICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Sector
  9.2.2. By Product Type
  9.2.3. By Service
  9.2.4. By Drug Type
  9.2.5. By Country
9.3. Competition Outlook
9.4. South America: Country Analysis
  9.4.1. Brazil Pharmaceutical Contract Manufacturing Market Outlook
    9.4.1.1. Market Size & Forecast
      9.4.1.1.1. By Value
    9.4.1.2. Market Share & Forecast
      9.4.1.2.1. By Sector
      9.4.1.2.2. By Product Type
      9.4.1.2.3. By Service
      9.4.1.2.4. By Drug Type
  9.4.2. Argentina Pharmaceutical Contract Manufacturing Market Outlook
    9.4.2.1. Market Size & Forecast
      9.4.2.1.1. By Value
    9.4.2.2. Market Share & Forecast
      9.4.2.2.1. By Sector
      9.4.2.2.2. By Product Type
      9.4.2.2.3. By Service
      9.4.2.2.4. By Drug Type
  9.4.3. Colombia Pharmaceutical Contract Manufacturing Market Outlook
    9.4.3.1. Market Size & Forecast
      9.4.3.1.1. By Value
    9.4.3.2. Market Share & Forecast
      9.4.3.2.1. By Sector
      9.4.3.2.2. By Product Type
      9.4.3.2.3. By Service
      9.4.3.2.4. By Drug Type

10. MIDDLE EAST AND AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Sector
  10.2.2. By Product Type
  10.2.3. By Service
  10.2.4. By Drug Type
  10.2.5. By Country
10.3. Competition Outlook
10.4. MEA: Country Analysis
  10.4.1. South Africa Pharmaceutical Contract Manufacturing Market Outlook
    10.4.1.1. Market Size & Forecast
      10.4.1.1.1. By Value
    10.4.1.2. Market Share & Forecast
      10.4.1.2.1. By Sector
      10.4.1.2.2. By Product Type
      10.4.1.2.3. By Service
      10.4.1.2.4. By Drug Type
  10.4.2. Saudi Arabia Pharmaceutical Contract Manufacturing Market Outlook
    10.4.2.1. Market Size & Forecast
      10.4.2.1.1. By Value
    10.4.2.2. Market Share & Forecast
      10.4.2.2.1. By Sector
      10.4.2.2.2. By Product Type
      10.4.2.2.3. By Service
      10.4.2.2.4. By Drug Type
  10.4.3. UAE Pharmaceutical Contract Manufacturing Market Outlook
    10.4.3.1. Market Size & Forecast
      10.4.3.1.1. By Value
    10.4.3.2. Market Share & Forecast
      10.4.3.2.1. By Sector
      10.4.3.2.2. By Product Type
      10.4.3.2.3. By Service
      10.4.3.2.4. By Drug Type

11. MARKET DYNAMICS

11.1. Drivers
11.2. Challenges

12. MARKET TRENDS & DEVELOPMENTS

13. COMPETITIVE LANDSCAPE

13.1. Competition Outlook
13.2. Players Profiled (Leading Companies)
  13.2.1. Jubilant Pharmova Limited
  13.2.2. JRS PHARMA GmbH & Co.
  13.2.3. Boehringer Ingelheim GmbH
  13.2.4. Lonza Group
  13.2.5. Rentschler Biotechnologie GmbH
  13.2.6. Inno Biologics Sdn Bhd
  13.2.7. INCOG BioPharma Services
  13.2.8. Baxter Biopharma Solutions
  13.2.9. Catalent Pharma Solutions
  13.2.10. Kemwell Biopharma Private Limited

14. STRATEGIC RECOMMENDATIONS